Drug Database
Back to search

Czechia· CZ-0241296

BLEOMYCIN ACCORD

A bleomycin product containing bleomycin sulfate, registered in Czechia by ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava. The same ATC class is registered in 15 of our 19 countries.

ATC L01DC01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedBLEOMYCIN ACCORDATCL01DC01REGISTER NO.CZ-0241296PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bleomycin sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bleomycin is registered in 15 of 19 countries.

Countries holding a registration under ATC L01DC01 (bleomycin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose
Search bleomycin products by name

Bleomycin · ATC L01DC01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BLEOMYCIN SULFATE
Manufacturer
ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
Country
Czechia (CZ)
ATC code
L01DC01
ATC class
Bleomycin
Defined daily dose
3 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0241296
    1
    CZK 1025.66

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

212 interactions on record for bleomycin.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bleomycin against other medicinesHow interaction checks work

Bleomycin · interactions on record

212 records

  • 33 severe
  • 105 moderate
  • 15 minor
  • 59 info

Most severe, free to view

  • CladribineL01BB04severe
  • Brentuximab vedotinL01FX05severe
  • Brentuximab vedotinL01XC12severe
  • Talimogene laherparepvecL01XL02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bleomycin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bleomycin products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Bleomycine Hikma
  • Germany · Bleomedac
  • Estonia · Bleomycin Medac
  • Finland · Bleomycin Baxter
  • France · Bleomycine Bellon
  • Italy · Bleoprim
  • Lithuania · Bleomycin Medac
  • Luxembourg · Bleomycine Hikma
  • Latvia · Bleomycin Medac
  • Poland · Bleomedac
  • Portugal · Bleocin
  • Slovakia · Bleomedac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/310f01ac-1a05-4119-a7ec-0a2d15fba6a3
GET /v1/drugs/310f01ac-1a05-4119-a7ec-0a2d15fba6a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ/INF PLV SOL",
  "source": "sukl",
  "strength": "15000IU",
  "pack_size": "1",
  "substance": "BLEOMYCIN SULFATE",
  "cz_kod_sukl": "0241296",
  "product_type": "CH",
  "substance_codes": "3309",
  "registration_state": "R",
  "registration_number": "44/428/16-C"
}
API referenceMCP serverPlans

See everything about bleomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console